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Methods For this reason, a theoretical model based on Markov chains is proposed to compare these strategies: fecal occult blood test, capsule endoscopy, once-life and twice-life colonoscopy, and no screening. The model predicts the health state of a population of individuals aged from 50 to 75 years.
Results
The numerical results show that the optimal timing for a once-lifetime colonoscopy screening method is before the age of 50 and that the twice-lifetime colonoscopy is the best screening strategy with respect to CRC incidence. In contrast, it is the most expensive one if the CRC treatment costs are not included. The model predicts that there is a minimal CRC incidence in the population when the second colonoscopy is appropriately timed. By using specific data, this age was found to be 59 years.
Conclusion The screening strategies probably save expenses on the treatment of the population and at the same time decreases mortality. Optimized twice-lifetime colonoscopy seems to be the most efficient strategy with respect to mortality and overall costs including subsequent treatment. Eur J Gastroenterol Hepatol 23:1157-1164 c Introduction According to epidemiological statistics, colorectal cancer (CRC) is one of the leading causes of cancer death in developed countries [1, 2] . Considering its high incidence and relatively high mortality, CRC is one of the most important problems within medical care, being further complicated by the fact that the majority of tumors is diagnosed at an advanced stage. However, CRC is often curable when it is found early. In particular, CRC affects a population aged more than 50 years, its incidence is the highest one in the population sample between 65 and 75 years. The CRC has long asymptomatic phase; therefore, a suitable CRC screening test can substantially reduce CRC mortality. There are several screening techniques available, for example, fecal screening tests that primarily detect colon cancer, structural tests [flexible sigmoidoscopy or colonoscopy, barium enema, computed tomography (CT) colonography] that may detect not only cancer, but also its precursors [3] . CRC screening tests differ one from another in their effectiveness, costs, complication rates, and patient compliance. There is a number of national screening programs, which are based on national specifics and recommendations of health organizations and expert panels, see for example [1, [4] [5] [6] [7] [8] . Some recommendations follow from analyses, which were accomplished based on the modeling of various CRC screening strategies and observation studies. These recommendations should answer questions concerning the choice of a suitable CRC screening method, the influence of compliance on cost-effectiveness, the optimal timing, and frequency of chosen screening methods.
The main motivation of this theoretical study is a comparison of various screening programs and optimization of their parameters. The majority of so far published theoretical models provide information specific to a particular population. For this reason, this study is particularly focused on general trends that can be observed in every population, when a particular screening strategy is applied. The results presented within this study could help to design a prospective observation study and subsequent CRC screening strategies on a national level.
The CRC treatment costs increase dramatically with the introduction of new procedures (e.g. new modalities of chemotherapy and biological therapy), which can significantly burden the health system financing. For the calculation of economic impact of the various screening programs, we considered the prices published in the study by Frazier et al. [1] . As prices of individual operations change approximately in the same proportions, we calculated the costs in the percentages to ensure their independence on trend in prices.
To evaluate the health and economic impacts of individual CRC screening strategies, we proposed a theoretical model based on Markov chains that simulates the evolution of polyps and CRC in the target generation, which is not included into any screening program and which is included into one of the following screening programs: once-lifetime colonoscopy, twice-lifetime colonoscopy, fecal occult blood test (FOBT), and capsule endoscopy (CE). The model also provides information with regard to the costs of the individual screening strategies.
Methodology
Within the theoretical model, it is assumed that the transition from a given state (probability of specific health state) to a future state depends only on the present state and not on the manner of reaching the current state. It means that the stochastic process is a Markov one [9] and especially one that the transition probabilities from one state to another are time independent (stationary) [1] . The health-state probabilities are determined in discrete time steps separated by 1 year (see Fig. 1 ).
The model was used to simulate the health-state evolution of one generation of people in the case when none or one of the four above mentioned CRC screening strategies is applied.
At the chosen age (50 years in this case), the group of people enters the simulation according to the assumed compliance. The state of health of this generation is given by the initial probability distribution (see Table 1 ). Furthermore, the time evolution of the state of health is calculated analytically by means of the year-to-year Markov transition probabilities [1] . With regard to the modeling of the group's health state, it is important to take into account the fact that the year-to-year transient probabilities and the initial probability distribution are related to each other. If this fact was ignored, the model would give paradoxical results that would be particularly evident from the graphs of time evolution of observed parameters. For this reason, we used the transition probabilities for determination of the initial probability distribution. The determined values lie within the ranges published in [1] .
Within this model, we assumed 60% compliance for the initial or follow-up colonoscopy (in the case of colonoscopy screening program) [1] and 100% for surveillance colonoscopy (it can be expected that a patient, who is willing to undergo one examination, will be also prepared to undergo the second planned examination), 80% for FOBT, and 80% for CE. The compliance of 83% for FOBT was confirmed by a previous Czech study [4] . The specificity for colonoscopy was assumed 100%, for FOBT 97% [1] , and for CE 75% [11] . The sensitivities of the used screening methods were chosen according to [1] and [13] (see Table 1 ).
To assess costs of individual screening programs, we adopted the prices presented in the study by Frazier et al. [1] . We estimate that the price of CE is $2500 (USD) [14] .
The health state of the target generation is followed (simulated) up to the age of 75 years, which represents approximately the life expectancy. Moreover, this time limitation is introduced to eliminate erroneous results due to assumed time independence of the year-to-year transition probabilities, that is, longer time interval would result in deviation from modeled reality.
The colonoscopy screening strategy was proposed as follows (see Fig. 2 ). If the state of health of the patient is good, the subsequent state of health course obeys the year-to-year transition probabilities up to the age of 75 years corresponding to life expectancy. If a polyp is found within the initial screening, the polypectomy is carried out and the state of health is considered to be good. Patients after polypectomy are tested by the surveillance colonoscopy again in 5 years. This period was chosen with the respect to the method sensitivity, as the time span of 5 years represents the average development of the CRC [7] . If cancer is found during the screening, the patient is excluded from the screening program as he/she undergoes oncology treatment.
In the case of twice-lifetime colonoscopy screening strategy, the people who were noncompliant within the first colonoscopy and the ones whose health status was good at the time of this examination undergo (again with regard to compliance of 60%) the follow-up colonoscopy.
In the case of FOBT the screening strategy, see Fig. 3 , it is assumed that each patient (according to the expected compliance) undergoes this test every 2 years from the age of 50 years. If the FOBT is positive, then he/she undergoes colonoscopy. After a negative colonoscopy test, the individual continues in FOBT testing. After a positive colonoscopy test, the patient continues as in the case of the once-lifetime colonoscopy screening strategy.
The strategy for CE screening, see Fig. 4 , is similar to the FOBT screening strategy with the difference that a patient undergoes CE screening only once (at the age of 50 years). This strategy was designed with respect to the fact that the CE method is the most expensive one. 
Results
The model shows that the optimal timing for the oncelifetime colonoscopy screening method is before 50 years of age. However, it can be expected that compliance would be low. In addition, it is necessary to take into account that the assumed time independence of the yearto-year transition probabilities would probably result in false results for the extended time span of modeling. Nevertheless, this result can be understood that it is preferable to start the screening sooner than later, which means that the age of 50 years is more suitable than, for instance, the age of 55 or 60 years that has been considered in some published screening strategy proposals [15] . To find the optimum age of the second colonoscopy in the case of the twice-lifetime colonoscopy screening strategy, the dependence of the number of patients with CRC in the population (between the ages of 50 and 75 years) on the age when it is executed, was calculated, see Fig. 5 . It can be observed that the dependence is not monotonous; it posses a minimum, in our case at the age of 59 years (it is necessary take into account the fact that parameters used in the model are connected with a specific population, thus we can assume that in other cases the optimal age need not be the same one). The determined optimal age of 59 years was used in the simulated twice-lifetime colonoscopy screening method. Furthermore, the optimal age of the second colonoscopy was looked for in reference to a number of patients with polyps in the population. In this case, the minimum can be attained when the second colonoscopy is executed at the age of 61 years. Fig. 6 shows the evolution of the number of healthy people in one generation (containing100 000 individuals). The saws in the time courses represent a follow-up screening test execution and subsequent polypectomies when polyps are found. From this figure, it is evident that the screening strategy based on FOBT preserves a number of healthy people on an approximately constant value. The best results are attained by the twice-lifetime screening colonoscopy strategy. It is also apparent that no screening program results in a considerable decrease of healthy people especially in later years.
In Fig. 7 , it can be seen that the strategy based on twicelifetime colonoscopy screening minimizes the number of patients with CRC in each age of their life. With regard to the number of people dead due to CRC in one generation, the best results are achieved by the twicelifetime colonoscopy (see Fig. 8 ).
These Figs 6-8 demonstrate that the strategy based on CE is comparable with the strategy based on oncelifetime colonoscopy. Comparison of various strategies for CRC Wohl et al. 1161 Fig. 9 compares expenses on individual screening strategies. It is self-evident that the strategy based on the CE method is the most expensive. Costs of once-lifetime and FOBT screening strategies are comparable.
Four bar graphs that compare individual CRC screening strategies for the entire population of individuals aged from 50 to 75 years are shown in Fig. 10 . With regard to the number of people in the supposed states of health within the population (healthy people, people with polyps, people with CRC) and a number of people who are dead due to CRC, the most successful CRC screening strategy is based on twice-lifetime colonoscopy and the least successful one is based on FOBT.
Discussion
Results obtained within this study show that the most successful strategy in the reduction of CRC mortality is the twice-lifetime colonoscopy with respect to its appropriate timing. But this strategy is the most expensive one. However, if we included the costs connected with CRC treatment into economic appraisal, this strategy would probably be the most favorable one. This conclusion is supported, for instance, by Wong et al. [16] .
CRC treatment costs have increased dramatically during the past years. From the early 1990s to 2003, treatment costs per person have increased by up to 200%, depending on the stage of disease at diagnosis, whereas unit screening costs did not increase so substantially [17, 18] . For example, in 2001, the price of distant CRC (stages III and IV) was approximately $ 80 000 (USD) and in 2010 it increased up to $ 500 000. This fact supports the importance of any screening [10] .
The cost-effectiveness of CRC screening in Europe and Asia is more favorable than in the USA and many studies have shown even cost-saving [19] [20] [21] .
FOBT is still the gold standard of screening in many countries. Within the model, the FOBT has been assumed with following colonoscopies in FOBT-positive cases. In addition, the false-positive results were incorporated into the model resulting in the increase of the cost of the FOBT program. As it is known, FOBT is distinguished by relatively low sensitivity and specificity, see for example [1, 4] , its advantage is relatively high compliance [4] .
Flexible sigmoidoscopy (FS) does not allow viewing of the entire colon and sex differences increase the importance of colonoscopy (optical, CT, CE). Women have more neoplasia located in the proximal colon [6, 22] and therefore, it can be assumed that the FS, as the screening method, is likely to be gradually replaced by less-invasive imaging methods (CT colonography, CE). For these reasons, although the FS is still the standard screening method, it was not included in the model.
Stool DNA tests having sensitivity of 80% for the CRC are still too expensive and their effectiveness depends on good compliance [19, 23] . The new noninvasive screening modalities such as CT colonography, stool DNA, and CE are not (yet) cost-effective compared with FOBT and endoscopy screenings [19] . Every positive noninvasive screening test is always followed by colonoscopy, which further increases the overall costs. On the basis of our model, we suppose the colonoscopy as a more suitable screening method.
The numerical results indicate that the optimal timing for a once-lifetime colonoscopy screening method is before 50 years of age. However, it can be expected that compliance would be lower than in the case of 50 years of age.
As it is rather plausible, it can be expected (and the model confirms this assumption) that suitable timing of the second colonoscopy within twice-lifetime colonoscopy strategy is not arbitrary, there is an optimal age. The optimal timing depends on statistical parameters that can be supposed to be specific for individual populations, that is, there is not a general recommendation in this respect.
Considering the fact that colonoscopy is an invasive procedure, it may be contraindicated in some patients, it has associated procedure risks, including the need for conscious sedation. From this point of view, the concept of capsule colonoscopy (CE) appears to represent a safe and promising new technology of visualizing the colon. The favorable results provided by the model issue from expectable high compliance and relatively high sensitivity.
If we assumed the sensitivity of only 56% according to the Israeli study [24] , then the CE method would provide worse results [24] . Hence, when equal compliance as in the case of colonoscopy was incorporated into the model, the colonoscopy program was more effective and substantially less compared with CE. The same conclusion was presented, for example, in the study [25] . Within CE, higher compliance can be expected, because it is executed without intubations, insufflations, sedation, radiation, and it is applied painlessly and enables direct visualization that represents the benefits of this method. It can be assumed that if the price of CE decreases, then colon CE will be a promising new modality for colonic evaluation.
We are aware of the fact that the model possesses some limitations, as we adopted several simplifying presumptions discussed in the work [6] . We suppose that the yearto-year transient probabilities are time independent. It would be straightforward to incorporate time-varying parameters into the model. Unfortunately, the relevant data are not yet available. We believe that this situation represents a challenge for the further investigation in this field of research. To minimize the digression of the model's predictions from reality, we limited its performance to 25 years. Furthermore, we did not consider the possibility that CRC can arise hereditary syndromes and de novo and as well, that is, without polyps, see for example [26] . In contrast, it can be assumed that only a small proportion of tumors arise in this carcinogenic way. The below listed facts also somewhat limit the explanatory capabilities of the model. The timing of colonoscopy should be based on the natural evolution of CRC carcinogenesis of the specific population, where significant differences can be observed [6, 22] . Available data point to differences in the incidence and localization of neoplasm for men and women and therefore the screening programs should be modeled separately for both the genders. Women also have higher incidence of CRC in the proximal colon [27, 28] . Moreover, there is evidence of a racial factor in CRC risk [27, 29] and significant differences can be observed in the incidence of CRC among ethnic populations, which should be reflected in the CRC screening models. For example, the Czech Republic has one of the highest incidences of CRC in the world [4] .
According to the theoretical model, we can conclude that twice-lifetime colonoscopy is the best strategy with respect to mortality and probably even to overall cost in case of subsequent treatment of CRC. Furthermore, the model unambiguously shows the importance of appropriate timing of both the once-lifetime and twice-lifetime colonoscopies, which must be based on the data for the target population.
For more accurate and complex economic evaluation of the screening programs, it would be necessary to supplement the model with data from CRC treatment costs. Unfortunately, the appropriate information is not available to us at present. We suppose that this issue poses a challenge for further research in this area. Despite this, we hope that the presented results will help to plan screening strategies on a country level.
